Vor Biopharma Announces Board and Executive Changes
Ticker: VOR · Form: 8-K · Filed: Jun 10, 2024 · CIK: 1817229
| Field | Detail |
|---|---|
| Company | Vor Biopharma Inc. (VOR) |
| Form Type | 8-K |
| Filed Date | Jun 10, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, executive-compensation
Related Tickers: VORB
TL;DR
Vor Bio's board and exec comp got a shake-up on June 4th.
AI Summary
Vor Biopharma Inc. announced on June 4, 2024, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and the election of new directors, alongside updates to compensatory plans for key personnel. Specific details regarding the individuals involved and the financial implications of these compensatory arrangements are outlined in the report.
Why It Matters
Changes in leadership and executive compensation can signal shifts in company strategy or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in executive and board composition can indicate internal shifts that may affect future strategy and performance.
Key Players & Entities
- Vor Biopharma Inc. (company) — Registrant
- June 4, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-39979 (commission_file_number) — SEC File Number
- 100 Cambridgepark Drive, Suite 101, Cambridge, Massachusetts 02140 (address) — Principal Executive Offices
- (617) 655-6580 (phone_number) — Registrant's telephone number
FAQ
What specific items are covered in this 8-K filing?
This 8-K filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing was on June 4, 2024.
What is the exact name of the registrant?
The exact name of the registrant is Vor Biopharma Inc.
In which state was Vor Biopharma Inc. incorporated?
Vor Biopharma Inc. was incorporated in Delaware.
What is the principal executive office address for Vor Biopharma Inc.?
The principal executive office address is 100 Cambridgepark Drive, Suite 101, Cambridge, Massachusetts 02140.
Filing Stats: 874 words · 3 min read · ~3 pages · Grade level 10.9 · Accepted 2024-06-10 16:05:53
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share VOR Nasdaq Glob
Filing Documents
- d847248d8k.htm (8-K) — 26KB
- 0001193125-24-158320.txt ( ) — 149KB
- vor-20240604.xsd (EX-101.SCH) — 3KB
- vor-20240604_lab.xml (EX-101.LAB) — 18KB
- vor-20240604_pre.xml (EX-101.PRE) — 11KB
- d847248d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Vor Biopharma Inc. Date: June 10, 2024 By: /s/ Robert Ang Robert Ang Chief Executive Officer